Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × talimogene laherparepvec × 1 year × Clear all

Sponsor

Conditions

Sarcoma 4 Breast Neoplasms 3 Triple Negative Breast Neoplasms 1 Sezary Syndrome 1 Paget Disease, Extramammary 1 Neurofibromatosis 1 1 Neurofibromatoses 1 Neurofibroma 1 Neoplasm Metastasis 1 Mycosis Fungoides 1 Muir-Torre Syndrome 1 Microcystic adnexal carcinoma 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Eccrine Porocarcinoma 1 Carcinoma, Signet Ring Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Ductal, Breast 1 Carcinoma, Ductal 1 Carcinoma, Basosquamous 1 Carcinoma, Basal Cell 1 Adenocarcinoma, Papillary 1

Interventions

Bevacizumab 59 atezolizumab 51 durvalumab 37 lenvatinib 35 pembrolizumab 33 Nivolumab 28 tremelimumab 23 Magnetic Resonance Spectroscopy 18 Specimen Handling 16 Sorafenib 16 Ipilimumab 13 tislelizumab 12 regorafenib 12 cabozantinib 12 apatinib 11 Radiosurgery 11 Immune Checkpoint Inhibitors 11 sintilimab 10 camrelizumab 9 Blood Specimen Collection 9 Radiotherapy 8 Immunoglobulin G 7 Cyclophosphamide 7 X-Rays 6 Hepatectomy 6 Disulfides 6 donafenib 5 Surgical Procedures, Operative 5 Fluorouracil 5 fludarabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡